SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-19-005326
Filing Date
2019-09-10
Accepted
2019-09-10 13:22:05
Documents
6
Period of Report
2019-08-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K imle_8k.htm 8-K 20464
2 COMMON STOCK PURCHASE AGREEMENT imle_ex101.htm EX-10.1 33955
3 SHARE EXCHANGE AGREEMENT imle_ex102.htm EX-10.2 30754
4 SHARE EXCHANGE AGREEMENT imle_ex103.htm EX-10.3 30688
5 DEBT CONVERSION AND COMMON STOCK PURCHASE AGREEMENT imle_ex104.htm EX-10.4 65083
6 DEBT CONVERSION AND COMMON STOCK PURCHASE AGREEMENT imle_ex105.htm EX-10.5 50978
  Complete submission text file 0001477932-19-005326.txt   233225
Mailing Address 400 N. TUSTIN AVE. SUITE 225 SANTA ANA CA 92705
Business Address 400 N. TUSTIN AVE. SUITE 225 SANTA ANA CA 92705 714-667-7139
TransBiotec, Inc. (Filer) CIK: 0001425627 (see all company filings)

IRS No.: 260731818 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53316 | Film No.: 191084803
SIC: 2721 Periodicals: Publishing or Publishing & Printing
Assistant Director 5